Suppr超能文献

工程化软骨素的生物合成

Biosynthesis of Chondroitin in Engineered .

作者信息

Cheng Fangyu, Luozhong Sijin, Yu Huimin, Guo Zhigang

机构信息

Department of Chemical Engineering, Tsinghua University, Beijing 100084, P.R. China.

Key Laboratory of Industrial Biocatalysis (Tsinghua University), the Ministry of Education, Beijing 100084, P.R. China.

出版信息

J Microbiol Biotechnol. 2019 Mar 28;29(3):392-400. doi: 10.4014/jmb.1810.10062.

Abstract

Chondroitin, the precursor of chondroitin sulfate, which is an important polysaccharide, has drawn significant attention due to its applications in many fields. In the present study, a heterologous biosynthesis pathway of chondroitin was designed in a GRAS (generally recognized as safe) strain . and genes with host codon preference were synthesized and driven by promoter P, which was confirmed as a strong promoter via GFPuv reporter assessment. In a lactate dehydrogenase () deficient host, intracellular chondroitin titer increased from 0.25 to 0.88 g/l compared with that in a wild-type host. Moreover, precursor enhancement via overexpressing precursor synthesizing gene further improved chondroitin titers to 1.09 g/l. Chondroitin production reached 1.91 g/l with the engineered strain ΔL-CgCAU in a 5-L fed-batch fermentation with a single distribution M of 186 kDa. This work provides an alternative, safe and novel means of producing chondroitin for industrial applications.

摘要

硫酸软骨素的前体软骨素是一种重要的多糖,因其在许多领域的应用而备受关注。在本研究中,在一种公认为安全(GRAS)的菌株中设计了软骨素的异源生物合成途径。合成了具有宿主密码子偏好性的基因,并由启动子P驱动,通过绿色荧光蛋白uv(GFPuv)报告基因评估确认该启动子为强启动子。在乳酸脱氢酶(LDH)缺陷型宿主中,与野生型宿主相比,细胞内软骨素滴度从0.25 g/L增加到0.88 g/L。此外,通过过表达前体合成基因来增强前体,进一步将软骨素滴度提高到1.09 g/L。在5-L分批补料发酵中,工程菌株ΔL-CgCAU的软骨素产量达到1.91 g/L,单一分布M为186 kDa。这项工作为工业应用生产软骨素提供了一种替代、安全且新颖的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验